Physician
Kumar, Munish
Kumar, Munish was paid $154K by Medicaid between Jan 2018 and Oct 2023, across 8 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.
33Billing provider infoKUMAR, MUNISH
MONROE, NY 10950
MONROE, NY 10950
33aNPI1922409994assigned 09/10/2014
33bProvider typePediatrics Physician
28Total paid$154K
24GClaims1,962
24DCodes billed8
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#626 of 1,983
Median peer was paid$17K
This provider vs. median9.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33 | $873.45 | |
| 2019 | 86 | $4K | |
| 2020 | 161 | $5K | |
| 2021 | 649 | $52K | |
| 2022 | 894 | $81K | |
| 2023 | 139 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 59% | 936 | 875 | $90K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 26% | 279 | 275 | $40K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.2% | 456 | 452 | $11K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 67 | 61 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 31 | 31 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 12 | 12 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 31 | 31 | $775.00 |
| 90686 | <1% | 150 | 150 | $18.37 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.